Past Forum: 2019
Boston
Summary
The 2019 World Medical Innovation Forum will focus on Artificial Intelligence (AI) and its growing impact on clinical care.
This meeting brought together global leaders in the emerging discipline of artificial intelligence and machine learning for in-depth conversations on the fast-developing novel technologies that characterize the early era of adoption. Impact on patients, clinicians and systems were examined in depth. The Forum panels, consisting of industry and investment executives, teamed with Harvard clinical and research leaders, focused on patient interactions across care settings, and the role technology and data can play in advancing knowledge discovery and care delivery.
Keynoters
Peter Orszag, PhD
- Vice Chairman, Corporate and Investment Banking, Citigroup
Jean-François Formela, MD
- Partner, Atlas Venture
Honorable Alex Azar II
- Secretary of Health and Human Services,
Ash Carter
- U.S. Secretary of Defense, 2015–2017
Simon Stevens
- CEO, NHS England
Stefan Oelrich
- Member of the Board of Management, Bayer AG
- President, Pharmaceutical, Bayer AG
Nisa Leung
- Managing Partner, Qiming Venture Partners
Amy Abernethy, MD, PhD
- Deputy Commissioner, FDA
Mark Benjamin
- CEO, Nuance Communications
Diana Nole
- CEO, Wolters Kluwer Health
James Weinstein, DO
- SVP, Head of Innovation and Health Equity, Microsoft Healthcare
Kieran Murphy
- CEO, GE Healthcare
Nancy Brown
- CEO, American Heart Association
Vivian Lee, MD, PhD
- President, Health Platforms, Verily Life Sciences
Dawn Barry
- President and Co-Founder, LunaDNA
Robert Bradway
- CEO, Amgen
Seema Verma
- Administrator, Centers for Medicare and Medicaid Services
Bernd Montag, PhD
- CEO, Siemens Healthineers
Frans Van Houten
- CEO, Philips
Jensen Huang
- CEO, NVIDIA
Panels
Day One: Monday, April 8, 2019
Early career Harvard Medical School investigators kicked-off the World Medical Innovation Forum with rapid fire presentations of their high potential new technologies. Eighteen rising stars from Brigham Health and Massachusetts General Hospital highlighted the potential of their research in artificial intelligence, cognitive computation, machine learning, and big data in ten minute presentations. This session was designed for investors, entrepreneurs, investigators, donors and others who share a passion for accelerating the application of high impact technologies to the benefit of patients.
Discovery Café: Applying AI to Save Lives During the Opioid Crisis
- Moderator: Thomas Sequist, MD, Chief Quality & Safety Officer, PHS
- Bob Burgin, CEO, Amplifire Healthcare Alliance
- Carm Huntress, CEO, RxRevu Inc
- Sarah Wakeman, MD, Medical Director, Substance Use Disorder Initiative, MGH; Assistant Professor, Medicine, HMS
- Scott Weiner, MD, Director, Brigham Comprehensive Opioid Response and Education (B-CORE) Program, BH; Assistant Professor, HMS
Discovery Café: Community Hospitals: Key Component in Healthcare Transformation
- Moderator: Michael Jaff, DO, President, NWH, PHS, Professor of Medicine, HMS
- Fabien Beckers, PhD, CEO, Arterys
- Joanna Geisinger, CEO, TORq Interface
- John Miller, MD, Director, Retinal Imaging, MEE; Assistant Professor, Ophthalmology, HMS
- Lee Schwamm, MD, Director, Center for TeleHealth and Exec Vice Chair, Neurology, MGH; Professor, Neurology, HMS
- Tal Wenderow, CEO, Beyond Verbal
Discovery Café: Digital Management of Diabetes
- Moderator: Deborah Wexler, MD, Clinical Director, Diabetes Center, MGH; Associate Professor, HMS
- Marie McDonnell, MD, Section Chief and Director, Diabetes Program, BH; Lecturer, HMS
- Michael Meissner, PhD, CTO and VP, MED, Sanofi
- Joshua Riff, MD, CEO, Onduo
- Marie Schiller, VP, Connected Care and Insulins Product Development and Site Head, Cambridge Innovation Center, Eli Lilly
Discovery Café: AI and Its Impact on the Future of Emergency Care
- Moderator: Adam Landman, MD, VP and CIO, BH; Associate Professor of Emergency Medicine, HMS
- Peter Chai, MD, Assistant Professor, Emergency Medicine, BH, HMS
- Emily Hayden, MD, Attending Physician, Emergency Medicine, MGH; Instructor, Surgery, HMS
- Kohei Hasegawa, MD, Attending Physician, Emergency Medicine, MGH; Associate Professor, Emergency Medicine, HMS
- Sean Kelly, MD, CMO, Imprivata; Assistant Professor, Emergency Medicine, HMS
- Bijoy Sagar, VP, Chief Digital Technology Officer, Stryker
Discovery Café: Mental Health, Smartphone Apps and the Promise of AI
- Moderator: Sabine Wilhelm, PhD, Chief of Psychology; Director, OCD and Related Disorders Program, MGH; Professor, Psychology, HMS
- Jennifer Gentile, PsyD, SVP, US Clinical Operations, Ieso Digital Health
- Thomas McCoy, MD, Director of Research, Center for Quantitative Health, MGH; Assistant Professor, Psychiatry and Medicine, HMS
- Christopher Molaro, CEO, Neuroflow
- David Silbersweig, MD, Chairman, Department of Psychiatry, BH; Stanley Cobb Professor of Psychiatry, HMS
- Jeremy Sohn, VP, Global Head of Digital Business Development and Licensing , Novartis
Discovery Café: From Startup to Impact (Pharma and Diagnostics)
- Moderator: James Brink, MD, Radiologist-in-Chief, MGH; Juan M. Taveras Professor of Radiology, HMS
- Moderator: James Nicholls, Managing Director, Fitzroy Health
- Sarah Beeby, EVP, GM Lifesciences, Clinithink
- Charles Cadieu, PhD, CEO, Bay Labs
- JB Michel, PhD, SVP Data Science & GM USA, BenevolentAI
- Art Papier, MD, CEO, VisualDx
- Alex Zhavoronkov, PhD, CEO, Insilico Medicine, Inc
- Moderator: Susan Hockfield, PhD, Board Member, PHS; President Emerita and Professor of Neuroscience, MIT
- Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
- Alistair Erskine, MD, Chief Digital Health Officer, PHS
- Gregg Meyer, MD, Chief Clinical Officer, PHS; Professor of Medicine, HMS; 2019 Forum Co-Chair
1:1 Fireside Chat: Jensen Huang, CEO, NVIDIA
- Moderator: Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
- Jensen Huang, CEO, NVIDIA
Remarks: The Honorable Charlie Baker
- Introduction: Scott Sperling, Co-President, Thomas H. Lee Partners; Chairman of the Board of Directors, PHS
- The Honorable Charlie Baker, Governor of the Commonwealth of Massachusetts
RWE and Trial Optimization in the AI Era
- Moderator: Thomas Lynch, MD, EVP and CSO, R&D, Bristol-Myers Squibb
- Amy Abernethy, MD, PhD, Deputy Commissioner, FDA
- Michael Devoy, MD, EVP MA&PV and Bayer CMO, Bayer AG
- Josh Mandel, MD, Chief Architect, Microsoft Healthcare
- Vicki Seyfert-Margolis, PhD, CEO, My Own Med Inc.
- Stephen Wiviott, MD, Executive Director, Clinical Trials Office, PHS; Associate Professor of Medicine, HMS
- Moderator: Timothy Ferris, MD, CEO, MGPO; Professor of Medicine, HMS
- Nancy Brown, CEO, American Heart Association
- Kris Joshi, PhD, EVP, President, Network Solutions, Change Healthcare
- Simon Stevens, CEO, NHS England
Cardiovascular Care: Reinvented Through AI
- Moderator: Calum MacRae, MD, PhD, Vice Chair for Scientific Innovation, Department of Medicine, BH; Associate Professor of Medicine, HMS
- Heather Bell, PhD, SVP, Global Head of Digital and Analytics, Sanofi
- Mike Burke, Patient, Independent Recording Engineer, Burke Recording
- Sebastian Guth, PhD, President, Bayer Pharma Americas Region, Bayer
- Udo Hoffmann, MD, Chief Cardiovascular Imaging, MGH; Professor, Radiology, HMS
- Rahul Patel, EVP/GM, Healthcare and Life Sciences, Persistent Systems
1:1 Fireside Chat: Seema Verma, Administrator, Centers for Medicare & Medicaid Services
- Moderator: Sree Chaguturu, MD, Chief Population Health Officer, PHS; Assistant Professor, Medicine, HMS
- Seema Verma, Administrator, Centers for Medicare and Medicaid Services
Day Two: Tuesday, April 9, 2019
Implementing AI in Cancer Care
- Moderator: Constance Lehman, MD, PhD, Chief, Breast Imaging Division, MGH; Professor of Radiology, HMS
- Dawn Barry, President and Co-Founder, LunaDNA
- Regina Barzilay, PhD, Delta Electronics Professor, Electrical Engineering and Computer Science Department, MIT
- Gad Getz, PhD, Director, Cancer Genome Analysis, Broad Institute; Professor, Pathology, HMS
- Daphne Koller, PhD, CEO, insitro
Imagining Medicine in the Year 2054
- Moderator: Keith Flaherty, MD, Director, Clinical Research, Cancer Center, MGH; Professor of Medicine, HMS
- Noubar Afeyan, PhD, CEO, Flagship Pioneering
- Calum MacRae, MD, PhD, Vice Chair for Scientific Innovation, Department of Medicine, BH; Associate Professor of Medicine, HMS
- Marcela Maus, MD, PhD, Director, Cellular Immunotherapy Program, Cancer Center, MGH; Assistant Professor, Medicine, HMS
- Rudolph Tanzi, PhD, Vice-Chair, Neurology, Director, Genetics and Aging Research Unit, MGH; Joseph P. and Rose F. Kennedy Professor of Neurology, HMS
1:1 Fireside Chat: Ash Carter, U.S. Secretary of Defense (2015–2017)
- Moderator: Gregg Meyer, MD, Chief Clinical Officer, PHS; Professor of Medicine, HMS; 2019 Forum Co-Chair
- Ash Carter, U.S. Secretary of Defense (2015–2017)
1:1 Fireside Chat: Honorable Alex Azar II, Secretary of Health and Human Services
- Moderator: Gregg Meyer, MD, Chief Clinical Officer, PHS; Professor of Medicine, HMS; 2019 Forum Co-Chair
- Honorable Alex Azar II, Secretary of Health and Human Services
- Moderator: Anne Klibanski, MD, Interim President and CEO, Chief Academic Officer, PHS; Laurie Carrol Guthart Professor of Medicine, HMS; 2019 Forum Co-Chair
- Frans Van Houten, CEO, Philips
- Joerg Moeller, MD, PhD, EVP, Head, Pharmaceuticals Research and Development, Bayer AG
- Bernd Montag, PhD, CEO, Siemens Healthineers
- Kieran Murphy, CEO, GE Healthcare
IDG Program Announcement and Winners
The Innovation Discovery Grants (IDG) program aims to enhance the commercial outcomes of the Partners HealthCare community and increase its innovative potential. It is designed to stimulate new inventive concepts, identify areas of commercially significant scientific strength and accelerate commercialization of PHS intellectual assets. In 2018, the IDG program funded projects that focused on the advancement of opportunities where artificial intelligence can be used to improve clinical care.
Discovery Café: Provider Back Office of the Future
- Moderator: Peter Markell, EVP, Administration and Finance, CFO and Treasurer, PHS
- Ingeborg Garrison, CNO/VP of Strategic Advisory Services, Verge Health
- Kent Ivanoff, CEO, VisitPay
- Mary Beth Remorenko, VP, Revenue Cycle Operations, PHS
- Brian Robertson, CEO, VisiQuate
Discovery Café: Chief Digital Strategy Officer Roundtable
- Moderator: Alistair Erskine, MD, Chief Digital Health Officer, PHS
- Michael Anderes, Chief Innovation and Digital Health Officer, Froedtert Health; President, Inception Health
- Adam Landman, MD, VP and CIO, BH; Associate Professor of Emergency Medicine, HMS
- Aimee Quirk, CEO, innovationOchsner
- Richard Zane, MD, Chief Innovation Officer, UCHealth; Professor and Chair, Department of Emergency Medicine, University of Colorado School of Medicine
Discovery Café: Innovation Fellows: A New Model of Collaboration
- Moderator: Seema Basu, PhD, Market Sector Leader, Innovation, PHS
- Nathalie Agar, PhD, Research Scientist, Neurosurgery, BH; Associate Professor, Neurosurgery, Radiology, HMS
- Paul Anderson, MD, PhD, Chief Academic Officer, BH; SVP, Research, BH; K. Frank Austen Professor of Medicine, HMS
- Laurie Braun, MD, Partners Innovation Fellow, MGH and Boston Pharmaceuticals; Instructor in Pediatrics, HMS
- David Chiang, MD, PhD, Research Fellow, BH; Innovation Fellow, Boston Scientific
- David Feygin, PhD, Chief Digital Health Officer, Boston Scientific
- Peter Ho, MD, PhD, CMO, Boston Pharmaceuticals
- Harry Orf, PhD, SVP, Research, MGH; Principal Associate, HMS
Discovery Café: Last Mile: Fully Implementing AI in Healthcare
- Moderator: Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
- Katherine Andriole, PhD, Director of Research Strategy and Operations, MGH & BWH CCDS; Associate Professor, Radiology, HMS
- Samuel Aronson, Executive Director, IT, Personalized Medicine, PHS
- Peter Durlach, SVP, Healthcare Strategy & New Business Development, Nuance
- Seth Hain, VP of R&D, Epic
- Jonathan Teich, MD, PhD, Chief Medical Information Officer, InterSystems; Emergency Medicine, BH
Discovery Café: Reimagining Disease Management
- Moderator: Sree Chaguturu, MD, Chief Population Health Officer, PHS; Assistant Professor, Medicine, HMS
- Murray Brozinsky, Chief Strategy Officer, Conversa
- Jean Drouin, MD, CEO, Clarify Health Solutions
- Julian Harris, MD, President, CareAllies
- Erika Pabo, MD, Chief Health Officer, Humana Edge; Associate Faculty, Ariadne Labs; Associate Physician, BH; Instructor, HMS
Discovery Café: Standards and Regulation: The Emerging AI Framework
- Moderator: Brent Henry, Member, Mintz Levin
- Bethany Hills, Member/Chair, FDA Practice, Mintz Levin
- Michelle McMurry-Heath, MD, PhD, VP, Global Regulatory Affairs and International Clinical Evidence, Johnson & Johnson Medical Devices
- Bakul Patel, Associate Director, Digital Health, FDA
- Michael Spadafore, Managing Director, Sandbox Industries
Discovery Café: From Startup to Impact (Provider Solutions)
- Moderator: Meredith Fisher, PhD, Partner, Partners Innovation Fund, PHS
- Moderator: James Stanford, Managing Director, Fitzroy Health
- William Grambley, COO, AllazoHealth
- Gal Salomon, CEO, CLEW
- Brian Symmons, COO, Gauss Surgical
- Pelu Tran, CEO, Ferrum Health
- Ed Zecchini, CIO, Remedy Partners
China: AI Enabled Healthcare Leadership
- Moderator: James Bradner, MD, President, Novartis Institutes for BioMedical Research
- Terri Bresenham, Chief Innovation Officer, GE Healthcare
- Kuan Chen, CEO, Infervision
- Rujing Gong, Chairman and Co-Founder, Yidu Cloud
- Nisa Leung, Managing Partner, Qiming Venture Partners
- Jian Wu, PhD, CEO, Real Doctor Corporation Limited
1:1 Fireside Chat: Mark Benjamin, CEO, Nuance
- Moderator: Peter Slavin, MD, President, MGH; Professor, Health Care Policy, HMS
- Mark Benjamin, CEO, Nuance Communications
Getting to the AI Investment Decision
- Moderator: Meredith Fisher, PhD, Partner, Partners Innovation Fund, PHS
- Roger Kitterman, VP, Venture and Managing Partner, Partners Innovation Fund, PHS
- Adam Koppel, MD, PhD, Managing Director, Bain Capital Life Sciences
- Amir Nashat, PhD, Managing Partner, Polaris Partners
- Mike Nohaile, PhD, SVP, Strategy, Commercialization and Innovation, Amgen
- Jim Sinclair, Managing Director, Healthcare Group, Goldman Sachs
- Krishna Yeshwant, MD, Partner, GV; Instructor in Medicine, BH
1:1 Fireside Chat: Robert Bradway, CEO, Amgen
- Moderator: Jean-François Formela, MD, Partner, Atlas Venture
- Robert Bradway, CEO, Amgen
Consumer Healthcare and New Models of Care Delivery
- Moderator: Diana Nole, CEO, Wolters Kluwer Health
- Cuong Do, President, Global Strategy Group, Samsung; Founder, CareVisor
- Patricia Florissi, PhD, VP and Global CTO, Sales, Dell EMC
- Vivian Lee, MD, PhD, President, Health Platforms, Verily Life Sciences
- Kyu Rhee, MD, VP and Chief Health Officer, IBM Corporation
- James Weinstein, DO, SVP, Head of Innovation and Health Equity, Microsoft Healthcare
Day Three: Wednesday, April 10, 2019
Innovation Discovery Grant Awardee Presentations
- Moderator: David Louis, MD, Pathologist-in-Chief, MGH; Benjamin Castleman Professor of Pathology, HMS
- Moderator: Clare Tempany, MD, Vice-Chair, Radiology Research, BH; Ferenc Jolesz MD Professor of Radiology, HMS
1:1 Fireside Chat: Stefan Oelrich, Bayer AG
- Moderator: Betsy Nabel, MD, President, Brigham Health; Professor of Medicine, HMS
- Stefan Oelrich, Member of the Board of Management, Bayer AG; President, Pharmaceutical, Bayer AG
1:1 Fireside Chat: Deepak Chopra, MD, Founder, The Chopra Foundation
- Moderator: Rudolph Tanzi, PhD, Vice-Chair, Neurology, Director, Genetics and Aging Research Unit, MGH; Joseph P. and Rose F. Kennedy Professor of Neurology, HMS
- Deepak Chopra, MD, Founder, The Chopra Foundation
Using AI to Predict and Monitor Human Performance and Neurological Disease
- Moderator: Merit Cudkowicz, MD, Chief of Neurology, Co-Director, Neurological Clinical Research Institute, MGH; Julieanne Dorn Professor of Neurology, HMS
- Poppy Crum, PhD, Chief Scientist, Dolby Laboratories
- Husseini Manji, MD, Global Therapeutic Head, Neuroscience Janssen Research & Development
- Alfred Sandrock, MD, PhD, EVP and CMO, Biogen
- Isaac Galatzer-Levy, PhD, Vice President of Clinical and Computational Neuroscience, AiCure; Assistant Professor of Psychiatry, NYU School of Medicine
Disruptive Dozen: 12 Technologies That Will Reinvent AI in the Next 12 Months
- Moderator: Jeffrey Golden, MD, Chair, Department of Pathology, BH; Ramzi S. Cotran Professor of Pathology, HMS
- Moderator: Erica Shenoy, MD, PhD, Associate Chief, Infection Control Unit, MGH; Assistant Professor, Medicine, HMS
Sponsors
